Misclassification of UDCA treatment response in patients with primary biliary cholangitis (PBC) in the real-world setting
{{output}}
Introduction and objectives: Treatment response of ursodeoxycholic acid (UDCA) in primary biliary cholangitis (PBC) is assessed after 12 months by Paris II criteria. In the German PBC registry, individuals were stratified into ad... ...
